Return On Equity of Evelo Biosciences, Inc. from 30 Sep 2018 to 30 Sep 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Evelo Biosciences, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Sep 2023.
  • Evelo Biosciences, Inc. Return On Equity for the quarter ending 30 Sep 2023 was 313%.
  • Evelo Biosciences, Inc. annual Return On Equity for 2022 was -1976%, a 675% decline from 2021.
  • Evelo Biosciences, Inc. annual Return On Equity for 2021 was -255%, a 29% decline from 2020.
  • Evelo Biosciences, Inc. annual Return On Equity for 2020 was -198%, a 108% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Evelo Biosciences, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2023 313% +1612% 01 Jul 2023 30 Sep 2023
Q2 2023 581% +1392% 01 Apr 2023 30 Jun 2023
Q1 2023 -3492% -2923% -513% 01 Jan 2023 31 Mar 2023
Q4 2022 -1976% -1721% -675% 01 Oct 2022 31 Dec 2022
Q3 2022 -1299% -1069% -466% 01 Jul 2022 30 Sep 2022
Q2 2022 -811% -621% -326% 01 Apr 2022 30 Jun 2022
Q1 2022 -569% -403% -243% 01 Jan 2022 31 Mar 2022
Q4 2021 -255% -57% -29% 01 Oct 2021 31 Dec 2021
Q3 2021 -230% -70% -44% 01 Jul 2021 30 Sep 2021
Q2 2021 -190% -49% -35% 01 Apr 2021 30 Jun 2021
Q1 2021 -166% -40% -32% 01 Jan 2021 31 Mar 2021
Q4 2020 -198% -103% -108% 01 Oct 2020 31 Dec 2020
Q3 2020 -159% -87% -122% 01 Jul 2020 30 Sep 2020
Q2 2020 -141% -84% -146% 01 Apr 2020 30 Jun 2020
Q1 2020 -126% -79% -170% 01 Jan 2020 31 Mar 2020
Q4 2019 -95% -36% -62% 01 Oct 2019 31 Dec 2019
Q3 2019 -72% +29% +29% 01 Jul 2019 30 Sep 2019
Q2 2019 -57% 01 Apr 2019 30 Jun 2019
Q1 2019 -47% 01 Jan 2019 31 Mar 2019
Q4 2018 -59% 01 Oct 2018 31 Dec 2018
Q3 2018 -101% 01 Jul 2018 30 Sep 2018

Evelo Biosciences, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2022 -1976% -1721% -675% 01 Jan 2022 31 Dec 2022
2021 -255% -57% -29% 01 Jan 2021 31 Dec 2021
2020 -198% -103% -108% 01 Jan 2020 31 Dec 2020
2019 -95% -36% -62% 01 Jan 2019 31 Dec 2019
2018 -59% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.